Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation : a multicenter prospective analysis
Source
Frontiers in immunology - ISSN 1664-3224-14 (2023) p. 1-10
Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms : a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
Source
American journal of hematology - ISSN 0361-8609-98:4 (2023) p. 628-638
Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation-study on behalf of CMWP of the EBMT
Source
Bone marrow transplantation - ISSN 0268-3369-57 (2022) p. 633-640
Safety and efficacy of antibiotic de-escalation and discontinuation in high-risk hematological patients with febrile neutropenia : a single-center experience
Source
Open Forum Infectious Diseases - ISSN 2328-8957-9:3 (2022) p.
Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease : a retrospective study from the CMWP EBMT
Source
Bone marrow transplantation - ISSN 0268-3369-57:3 (2022) p. 499-501